Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.579
-0.072 (-11.00%)
At close: Nov 4, 2024, 4:00 PM
0.570
-0.009 (-1.47%)
After-hours: Nov 4, 2024, 7:59 PM EST
Ensysce Biosciences Employees
Ensysce Biosciences had 7 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$205,419
Profits / Employee
-$1,611,205
Market Cap
8.02M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | 0 | - |
| Dec 31, 2022 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 6 | 3 | 100.00% |
| Dec 31, 2020 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| XWELL | 337 |
| Addex Therapeutics | 23 |
| Virax Biolabs Group | 17 |
| Quantum BioPharma | 17 |
| Soligenix | 15 |
| GlucoTrack | 6 |
ENSC News
- 27 days ago - Ensysce Biosciences Announces Leadership Team's Participation in the Annual Pain Therapeutics Summit - Accesswire
- 4 weeks ago - Ensysce Biosciences Provides Shareholder Update, Responds to Recent Shareholder Inquiries - Accesswire
- 5 weeks ago - Ensysce Biosciences Receives Notice from Nasdaq - Accesswire
- 5 weeks ago - Ensysce Biosciences Presenting at Upcoming Meetings - Accesswire
- 6 weeks ago - Ensysce Biosciences Submits Phase 3 Protocol to the FDA - Accesswire
- 7 weeks ago - Ensysce Biosciences Posts Video Updates from the IASP World Congress on Pain 2024 - Accesswire
- 2 months ago - Ensysce Biosciences, Inc. Announces $5 Million Concurrent Registered Direct Offering and Exercise of Warrants - Accesswire
- 2 months ago - Ensysce Biosciences Announces IRB Approval for Key MPAR Study - Accesswire